FDA Inspection 1092596 — Fibrocell Technologies, Inc.
The FDA completed an inspection of Fibrocell Technologies, Inc. on May 21, 2019 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)
Additional Details
Sponsor, Contract Research Organization